ABSTRAm. We tested the hypothesis that high frequency oscillatory ventilation (HFOV) would result in decreased pulmonary barotrauma in infants with hyaline membrane disease by comparing HFOV at 10 Hz to conventional positive pressure ventilation with continual distending airway pressure (PPV/PEEP) in premature baboons with hyaline membrane disease. Nineteen baboon fetuses were randomized to one of two treatment groups, delivered at 140 * 2 days, and, after stabilization and instrumentation of PPVIPEEP, placed in their respective ventilator group. Animals on conventional ventilation were managed by adjustment of tidal volume and frequency (to 1 Hz) to keep PaCOz below 55 and by adjustment of the mean airway pressure. One of the "HFOV" group died of cardiovascular complications before going on HFOV and was eliminated from data analysis. The remaining HFOV baboons survived the 11-day experimental period without evidence of airleak. Six of the 11 prematures treated with PPV/PEEP developed pulmonary interstitial emphysema and/or pneumothorax and five of the animals died within 48 h. The intergroup differences in airleak were significant (p < 0.05). Mean airway pressure (measured at the proximal airway) was higher initially with HFOV but then was lowered more rapidly than in the PPVIPEEP animals. The arterial to alveolar oxygen ratio rose and the FIOZ could be lowered more rapidly with HFOV than with conventional ventilation. These differences reached significance by 20 h. After 60 h there were no significant differences between HFOV and the PPVIPEEP survivors. HFOV resulted in more uniform saccular expansion, higher arterial to alveolar oxygen ratio, less oxygen exposure, and decreased acute barotrauma when compared to PPV/ PEEP. Although initially mean airway pressure was in the HFOV animals this was not associated with measurable baroinjury. These data support the efficacy of HFOV in the treatment of prematures with hyaline membrane disease. (Pediatr Res 21: 594-602, 1987) Abbreviations HFOV, high frequency oscillatory ventilation -Paw, mean airway pressure HMD, hyaline membrane disease Pa/A 02, arterial to alveolar oxygen ratio HFV, high frequency, low volume ventilation FawOz, FawC02, I:E, inspiratory:expiratory ratio ANOVA, analysis of variance PIE, pulmonary interstitial emphysema HFV has been proposed as an alternative to conventional PPV/PEEP in the management of infants with HMD (1-4). Interest in this technique has been generated by the observation that, with an appropriate strategy, HFV can accomplish gas exchange at lower intrapulmonary intraluminal distending pressures, thus potentially reducing the risk of baroinjury (5-8).
instrumentation of PPVIPEEP, placed in their respective ventilator group. Animals on conventional ventilation were managed by adjustment of tidal volume and frequency (to 1 Hz) to keep PaCOz below 55 and by adjustment of the mean airway pressure. One of the "HFOV" group died of cardiovascular complications before going on HFOV and was eliminated from data analysis. The remaining HFOV baboons survived the 11-day experimental period without evidence of airleak. Six of the 11 prematures treated with PPV/PEEP developed pulmonary interstitial emphysema and/or pneumothorax and five of the animals died within 48 h. The intergroup differences in airleak were significant (p < 0.05). Mean airway pressure (measured at the proximal airway) was higher initially with HFOV but then was lowered more rapidly than in the PPVIPEEP animals. The arterial to alveolar oxygen ratio rose and the FIOZ could be lowered more rapidly with HFOV than with conventional ventilation. These differences reached significance by 20 h. After 60 h there were no significant differences between HFOV and the PPVIPEEP survivors. HFOV resulted in more uniform saccular expansion, higher arterial to alveolar oxygen ratio, less oxygen exposure, and decreased acute barotrauma when compared to PPV/ PEEP. Although initially mean airway pressure was in the HFOV animals this was not associated with measurable baroinjury. These data support the efficacy of HFOV in the treatment of prematures with hyaline membrane disease. HMD, hyaline membrane disease Pa/A 02, arterial to alveolar oxygen ratio HFV, high frequency, low volume ventilation FawOz, FawC02, I:E, inspiratory:expiratory ratio ANOVA, analysis of variance PIE, pulmonary interstitial emphysema HFV has been proposed as an alternative to conventional PPV/PEEP in the management of infants with HMD (1) (2) (3) (4) . Interest in this technique has been generated by the observation that, with an appropriate strategy, HFV can accomplish gas exchange at lower intrapulmonary intraluminal distending pressures, thus potentially reducing the risk of baroinjury (5) (6) (7) (8) .
The mechanisms of lung injury in infants with HMD are incompletely understood. Although most investigators believe that pulmonary immaturity, baroinjury, oxygen toxicity, and infection play a role in the pathogenesis of bronchopulmonary dysplasia, there is no general agreement about the relative importance of each factor (9-1 3). The premature baboon, delivered at 140 days gestation, develops HMD clinically, pathologically, and biochemically similar to that in man. When treated with positive pressure ventilation and exposed to 100% oxygen for periods from 8-14 days, these animals develop bronchopulmonary dysplasia (14, 15) . Because of its reproducibility and homogeneity this model offers the opportunity to explore potential therapeutic interventions directly in the premature and to assess both physiologic and pathologic endpoints. The purpose of these studies was to compare HFOV to PPV/PEEP in the management of premature baboons with HMD. We hypothesized that HFOV would result in diminished barotrauma and by so doing might substantially alter the short-term and long-term course of this disease. a continually recording POz electrode (Invivox catheter, Critikon, Tampa, FL) was inserted and positioned above the diaphragm. Baseline studies were performed as previously described (I 1). During the instrumentation period, the ventilator was then adjusted according to the following protocol: Pa02 was maintained between 50 and 80 torr by adjustment of the level of PEEP and inspiratory pressure at a fixed inspiratory duration (0.5-0.6 s) and/or by adjustment of the FI02. All animals were initially started on 4 cm H 2 0 PEEP. Initially the strategy was to raise the Haw until a rapid increase in Pa02 was observed on the continually recording O2 electrode. Subsequent decisions as whether to alter FI02 and Paw were in general made with the experimental goal of reducing the FI02 below 0.8 as soon as possible. PaC02 (measured by intermittent arterial sampling) was kept between 35 and 55 torr by adjustment of the ventilator frequency (up to 60 breaths per min) or inspiratory pressure. If oxygenation was adequate, the PaC02 above 55 ton, and the maximum frequency had not been reached, frequency was adjusted preferentially. If these changes did not result in a PaC02 within the protocol guidelines, inspiratory pressure was increased.
Airway pressure was measured at the proximal airway using a Validyne pressure transducer (model DP 45, Validyne, Northridge, CA) with linear calibration to 40 Hz. Airway pressure, blood pressure, Faw02 and FawC02 were continually recorded. A central venous catheter was inserted into the internal jugular vein for fluid administration. After all procedures had been completed, a set of blood gases and a chest radiograph were obtained and the animal was placed on the ventilator appropriate to the group to which they had been randomized.
-A fixed frequency of 10 Hz was used during HFOV. The initial Paw was determined by that used at the end of the instrumentation period_Thereafter oxygenation was optimized by adjustment of the Paw and/or FI02 with the goal being to maximize the Pa/A O2 ratio. PaC02 was kept within the range of 35 to 55 torr by adjustment of the delivered tidal volume. HFOV was provided using a piston oscillator powered by a linear motor (model SS-1, Texas Research Co., San Antonio, TX). This device can deliver a frequency between 1 and 50 Hz and has a variable I:E ratio. An I:E ratio of 1:2 was used in these studies. All HFOV baboons were sighed using the time cycled ventilator for 1 min of each hour at 30 breaths per min. The pressures initially utilized were those used at the end of the instrumentation period. As_the mean airway pressure subsequently could be reduced, the Paw during the sigh period was reduced an equivalent amount.
Ventilator management of the PPV/PEEP animals continued as it had in the instrumentation period. Since, in general, animals whose PaC02 exceeded 55 torr also had a low Pa/A 0 2 , inspiratory pressure (rather than ventilator frequency) was initially increased to improve ventilation. Frequency was preferentially altered (to a maximum of 60/min) when the PaC02 exceeded protocol guidelines while oxygenation was adequate or when it was believed that an increase in inspiratory pressure would be deleterious.
Animals were paralyzed with pancuronium bromide and sedated with ketamine hydrochloride throughout the first 48 h of the experiment. They then were allowed to breathe spontaneously. Sedation with ketamine and local anesthesia were administered for any invasive procedures.
Weaning was attempted after 48 h by decreasing the ventilatory rate and pressure in the PPV/PEEP animals and by decreasing -Paw and tidal volume during HFOV. Extubation was attempted if an animal had a PC02 less than 50 torr and a Pa02 greater than 50 torr in FI02 0.5. Animals were then kept on supplemental oxygen until they could maintain a Pa02 over 50 torr in room air or until sacrifice.
All baboons were initially begun on an intravenous solution of 5% dextrose with 500 mg of calcium gluconate per 250 ml and 2 U sodium heparin per ml at a rate of 150-200 ml/kg/day. NaCl and KC1 were added as indicated by measurement of serum electrolytes. After 48 h animals received total parenteral nutrition from a solution of amino acids, glucose, electrolytes, vitamins, and trace minerals calculated to deliver 2.25 g amino acids and 82 kcal/kg/day by the end of the 1st wk.
Arterial blood gases were measured hourly for the first 24 h, every 2 h between 24 and 48 h, every 4 h from 48 to 96 h, and every 8 h after 96 h until the animal was sacrificed. Serum electrolytes, blood urea nitrogen, and creatinine were measured daily. Dextrostix, urine specific gravity, and urine glucose were measured every 4 h. Hematocrit was determined every 4 h during the first 24 h and every 8 h thereafter. Blood was replaced volumetrically with either fresh citrate phosphate dextrose or heparinized blood from adult donors. Chest radiographs were obtained at 1, 2, 6, 12, 18, 24, 36, 48, 60, 72, and 96 h and daily thereafter. These were read by two observers without knowledge of the treatment group. Single shot angiograms were preformed at 1 h and as indicated thereafter by clinical signs of patent ductus arteriosus or by presence of retrograde flow in the femoral artery by continual wave Doppler ultrasound. All animals were treated with ampicillin (200 mg/kg/day) and gentamycin (5 mg/kg/day) for the duration of the experiments.
Based on our previous data (14, 15) , pathologic changes of bronchopulmonary dysplasia appear within 8-10 days of treatment with positive pressure ventilation and hyperoxia. We therefore chose 11 days as the endpoint in these studies. However, since pathologic endpoints were a critical factor in our study design, the level of supportive care in the event of catastrophic deterioration was limited. If, prior to the completion of the designated study period, an animal in either group developed cardiopulmonary complications which could not be reversed by simple resuscitative maneuvers as defined in the protocol, the experiment was terminated. Animals were sacrificed by an overdose of anesthesia.
Pathologic methods. Lung fixation consisted of perfusion of
quarter-strength Karnovsky's fixative through the pulmonary vascular system, while maintaining lung inflation at a constant transpulmonary pressure of 20 cm H 2 0 (16). After opening the thorax and examining the lungs grossly, the ductus arteriosus was located and tied off. The right ventricle was opened and a catheter placed in the main pulmonary artery and secured. The left auricle was opened to allow the perfusate to escape. The lungs were slowly inflated using 20 cm H20 pressure and the trachea was then cross-clamped. Lungs were flushed of blood with an iso-osmotic/iso-oncotic Hanks' balanced salt solution for approximately 1 min at 30-40 mm Hg perfusion pressure, followed immediately by the infusion of Karnovsky's fixative for a minimum of 20 min. After the perfusion, the entire heart-lung preparation was removed en bloc from the chest and floated in additional fixative until the lungs were cut and embedded for light and electron microscopy studies 24 h later. All other organs were examined and fixed for microscopic study. Necropsy was performed at the time of sacrifice or within 30 min of death.
Statistical methods. Physiologic data collected on each animal every hour during the first 20 h was analyzed by ventilator group and by survivors using analysis of variance for repeated measures. The 20-h time point was chosen as the endpoint for this analysis because the first death in the PPV/PEEP group occurred at 2 1 h and all data sets were complete prior to this point. For FI02 and Pa/A 02, linear regression analysis of the data during the instrumentation period and for the first 3 h after assignment to a specific ventilator yielded slopes for each animal which were compared between groups by unpaired t test.
Longitudinal data, including only surviving animals, was compiled using the physiologic data collected every hour during the first 24 h and every 2 h from this point until death or completion of the experiment. These data were averaged over 6-and 8-h intervals, respectively. If more than 50% of the data points were missing for any interval, the interval calculation was considered a missing value for each animal. Interval means were pooled by group at each time point for statistical analysis. Analysis of variance of repeated measures was used to determine the signif-icance of intergroup differences in the longitudinal data. Group means at specific time points were also compared by unpaired t test.
Specific clinical endpoints (airleak, mortality) were compared among groups using either Fisher's exact test or the variable x2 Chronbach's a test. The t test was used to test for any ventilator effect among groups. The mean of the raters' scores was calculated and the lobe scores were summed for each animal.
RESULTS
One of the baboons assigned to the HFOV group died with cardiovascular complications during the instrumentation period. Since it was never actually placed on the oscillator, data from this animal have been excluded from analysis.
Mean birth weight was 533 + 27 g in the PPV/PEEP and 575 & 26 in the HFOV animals. The instrumentation period lasted between 1.8 and 2.6 h (mean 2.3 h). There were no significant differences in FI02, peak airway pressure, mean airway pressure, Pa02, PaC02, or Pa/A O2 between the two groups of animals prior to placement on their designated ventilators at the end of the instrumentation period (Table 1) . Fig. 3. FI02 , paw, and Pa/A O2 (mean + SD) for all surviving
Time (hours)
animals. The open circle represents the end of the instrumentation period and the first data is plotted at the midpoint of the first averaged interval. Note that at 42 h significant recovery occurred in both ventilator groups. After 60 h there were no significant differences among survivors. Mean airway pressure (measured at the proximal airway) was initially higher with HFOV but stabilized after 8 h at a slightly lower level (Fig. 1) . In contrast, PPV/PEEP-treated prematyres siarted at lower mean pressures but required an increase in Paw between 4 and 10 h to maintain their Pa02 in the desired range. Between 10 and 60 h there was a consistent trend towards higher mean airway pressures in the surviving PPV/PEEP as compared to the HFOV animals. These intergroup differences did not reach statistical significance. Peak airway pressures for the PPV/PEEP group had to be increased from 32 to 39 cm H 2 0 between 4 and 10 h in order to keep the PaC02 below 55 tom. The requirement for increased mean and peak airway pressures in this time frame occurred in all but one of the animals on conventional ventilation. After 24 h of age there was a progressive decrease in the requirement for peak airway pressure in the surviving PPV/ PEEP baboons.
FT02 remained high in the PPV/PEEP animals and could be lowered only from 0.68 to 0.65 over the first 20 h. In contrast, there was a significant decrease in FI02 within 3 h of institution of HFOV with an overall decrease from 0.65 to 0.38 by 20 h. Both the differences in slope and in FI02 by 20 h were statistically significant (p < 0.05). There were no intergroup ventilatorassociated differences in Pa02 during this period (Fig. 2) . The Pa/A O2 of the conventionally ventilated baboons remained essentially unchanged over the first 20 h (Fig. I) . Within 3 h of initiating HFOV, there was a significant increase in Pa/A O2 in these animals compared with controls. Pa/A O2 continued to improve in this group, with the intergroup difference by ANOVA reaching significance by 20 h.
Between 42 and 60 h, there was marked improvement in oxygenation and a concurrent reduction in mean airway pressure in the surviving PPV/PEEP animals (Fig. 3) . This was m_anifested by a significant rise in Pa/A 0 2 and fall in FIO2 and Paw over time. There were similar trends in the HFOV animals but, because at 42 h they already had significantly lower Pa/A O2 and H 0 2 , only the decrease in Paw after 42 h reached statistical significance compared with the previous time interval. After 48 h, there were no significant intergroup differences (by ANOVA or t test) in n o 2 , Pa/A 02, PaC02, or Paw between the HFOV and the surviving PPV/PEEP prematures (Figs. 3 and 4) . All of the animals surviving over 46 h were extubated prior to sacrifice < 0.05). The five remaining surviving animals in this group had no evidence of airway disruption or bronchopulmonary dysplasia. Varying degrees of focal atelectasis were present. Bronchoalveolar hemorrhages were seen in two of the PPV/PEEP baboons at 1 1 days. All seven HFOV animals survived the 1 I-day experimental period. None had evidence of BPD at necropsy (Fig. 7) . Bronchoalveolar hemorrhages were found in three of the seven HFOV animals.
Analysis of data derived from the panel of standards grading method revealed a high degree of interobserver reliability with a = 0.9732. There were no significant differences in lung inflation pattern among lobes or between ventilator groups when comparing those animals surviving the entire experimental period. at 11 days.
Five of the 1 1 baboons treated with positive pressure ventilation developed massive air leak and died between 21 and 46 h ( Table 2) . Although in each animal death resulted from cardiopulmonary failure, radiographic and clinical evidence of PIE/ pneumothorax preceded that of hypotension and shock, and cardiovascular collapse appeared to be related to unsuccessful attempts to maintain satisfactory ventilation at high ventilation pressures. At necropsy their lungs showed hyaline membrane disease, poor saccular aeration, airway dilatation, pulmonary interstitial emphysema and pseudocyst formation (Fig. 5 A and  B) . The remaining animals in the PPV/PEEP group survived the entire experimental period. 'Those that ultimately survived had a strong trend toward higher Pa/A O2 and lower FI02 after 10 h of age (Fig. 6 ) than did those who later died with air leak. These intragroup differences were apparent well before any of the animals developed radiographic evidence of PIE or pneumothorax. There were, however, no significant differences in mean or peak airway pressures between subsets prior to the recognition of radiographic changes.
One of the 1 1-day PPV/PEEP survivors was found to have pseudocysts at necropsy. The overall difference in the incidence of air leak between the two ventilator groups was significant (p
DISCUSSION
In these studies premature baboons with HMD treated with HFOV had a significant decrease in acute baroinjury resulting in increased survival compared with those treated with PPV/ PEEP. This appeared to correlate with more uniform lung inflation in the first 24 h. The differences in saccular expansion resulted, directly or indirectly, in higher Pa/A O2 and lower oxygen exposure in the HFOV animals. Although initially higher, mean airway pressures could be reduced more rapidly during HFOV, supporting our previous 24-h morphologic observations resembling human HMD. We have previously shown that, by that there were ventilator-related structural and functional pul-24 h of age, baboons with HMD ventilated with PPV/PEEP had monary differences (1 8).
striking maldistribution of intrapulmonary gas with poorly exThese experiments gave us a unique opportunity to correlate panded saccules and dilated, overdistended distal conducting morphologic and physiologic findings in an animal model closely airways. In contrast, prematures treated with HFOV had more 0 . 9 .
distal mean pressure and that the intrapulmonary pressures were considerably higher (25) . This would be unlikely with the HFOV Fig. 6 . n o 2 , Paw, and Pa/A 0 2 ratio during the first 20 h in the strategy used since the I:E ratio was 1:2 and the frequency was PPVIPEEP animals who survived compared to those who died. Note a only 10 Hz. Even if there were an increase in Paw, it did not trend toward lower Pa/A ratio and FlO2 before there was any radi-appear to be of significance since there was no baroinjury in this ographic evidence of air leak.
group and no radiographic evidence of hyperinflation.
When the data were examined over time, we found that from 10 to 20 h, the ratio of Pa/A O2 to Paw rose significantly in the uniform saccular inflation and less small airway dilatation. _The HFOV animals suggesting that their lxngs were functionally similarities between the clinical course, Pa/A 0 2 , FI02, and Paw improving. During the same interval, Paw in the PPV/PEEP in the first 24 h in these experiments and those earlier data treated prematures had to be increased to maintain the same Pa/ suggest that the morphology at 24 h was similar in both studies. A 02. This is similar to the findings of Nilsson and others (20, Therefore, nonuniform lung inflation appears to be characteristic 2 1, 26) and suggests that positive pressure ventilation results in of hyaline membrane disease during treatment with conventional additive lung injury in the surfactant deficient lung. In addition, positive pressure ventilation. Hawker et al. (19) described similar the observation that the ratio between Pa/A O2 and paw inpathology in human infants dying after ventilator treatment of creased with HFOV during this same period supports the possisevere HMD. Nilsson and coworkers (20,2 1) noted that the high bility that HFOV (or the use of a high mean airway pressure) airway pressures needed to ventilate the preterm rabbit lung actually enhances functional development of the immature lung. resulted in nonhomogeneous expansion with overinflation of the Kolobow and coworkers (27, 28) have described rapid immore compliant segments. From our observations it is clear that provements in lung compliance in immature lambs on partial pathologic small airway overdistension occurs during PPV/PEEP bypass after keeping the lungs inflated at constant pressure. It is in baboon prematures with HMD and it is our notion that possible that HFOV acts like constant pressure at the saccular further dilatation of these airway segments leads to loss of struc-level and improves alveolar stability by some combination of tural integrity and pulmonary interstitial emphysema, pseudo-enhanced surfactant synthesis, decreased turnover or prevention cyst formation and pneumothorax (22) .
of additive lung injury (29, 30) . Lastly, the study design utilized We found a high incidence of airleak associated with high PPV/PEEP in both treatment groups during the initial stabili- mortality in the baboon prematures ventilated with PPVIPEEP. The peak ventilation pressures in these animals were high but still did not result in adequate alveolar ventilation prior to development of air leak. In contrast, HFOV resulted in more uniform lung inflation, less acute baroinjury, and better survival. The mechanisms underlying these intergroup differences are complex.
Early interest in HFOV centered on its ability to accomplish adequate gas exchange with low tidal volumes and presumably less risk of baroinjury. Although we did not measure intrapulmonary pressures in these studies, there is no question that the intrapulmonary peak to peak pressure swings during HFOV at 10 Hz were lower than those during PPV/PEEP (23) . While this could account in part for the difference in acute air leak between the two ventilator groups, it cannot explain all of the observations.
Initially, animals on HFOV were subjected to higher Haw than were those on conventional ventilation. This resulted from an experimental design which was aimed at comparing the effects of an "optimal" HFOV stratgy to one commonly used during conventional ventilation of human prematures. After the initiation of HFOV, Paw was set at a level which resulted in a rapid increment in oxygenation. Further adjustment of the Paw was dependent on the Pa02 response during the sigh maneuver. This strategy, while leading to initially higher mean airway pressures during HFOV, did not result in detectable airway disruption or significant intergroup differences in blood pressure or metabolic acidemia. The rapid increase in Pa/A O2 seen early in the HFOV animals may well have resulted from the higher paw and is consistent with the hypothesis that the ideal ventilatory support in HMD is one in which a high, near constant, airway pressure is applied (24) . With the strategy used, PPV/PEEP animals had relative hypoventilation and a high incidence of acute baroinjury and it is unlikely that they would have tolerated Paw at the levels used during HFOV. These observations suggest that peak distending pressure rather than mean airway pressure is the critical factor in the development of PIE in infants with HMD and that one advantage of HFOV is the ability to safely use a high mean airway pressure.
After 10 h animals on HFOV achieved higher Pa/A O2 at lower proximal Paw. This would appear to contradict exte~sive data relating oxygenation in diffuse alveolar disease to the Paw. Since we measured mean pressure only at the proximal airway, it is possible that this measurement was not representative of zation period in order to allow us to compare disease severity prior to ventilator assignment. Had we compared PPV/PEEP to the immediate institution of HFOV, the morphologic and physiologic differences between ventilator groups may have been more striking. Additional experiments using HFOV as the sole mode for ventilatory support and focusing on this critical early window will help to further define the relative role of each of these potential mechanisms.
-After 42 h, there was a significant decrease in requirement for Paw and a rise in Pa/A O2 in the HFOV and the surviving PPV/ PEEP animals. By 96 h, there were no longer any ktergroup differences in lung inflation patterns, Pa/A 0 2 , or Paw. This recovery presumably was associated with the appearance of functionally adequate levels of alveolar surfactant, was independent of ventilator mode, and occurred despite substantial differences in the magnitude and duration of oxygen exposure between the two ventilator groups. It is also consistent with our previous experience (17) . From this we can conclude that the relative hyperoxia in the PPV/PEEP animals did not result in additive lung injury. We have previously shown that the premature baboon (140 + 2 days) with HMD is susceptible to oxygen injury and develops bronchopulmonary dysplasia after prolonged treatment with positive pressure ventilation and FI02 1.0 (14, 15) . With the degree of oxygen exposure obtained in these experiments, recovery in the surviving PPV/PEEP animals occurred early and the changes of BPD were not seen. This observation has important clinical and physiologic implications. Most investigators have implicated oxygen injury or pulmonary barotrauma in the pathogenesis of bronchopulmonary dysplasia. The results of these studies and others (3 1) suggest that chronic pulmonary baroinjury may not occur except in the presence of persistent parenchymal pulmonary disease. It further suggests the possibility that the major benefit of HFOV in the treatment of infants with HMD occurs early in the course of the illness and that there may be no particular advantage to its continued use once there has been significant resolution of the underlying disease process. significant morphologic differences between the HFOV and the 11 day
The physiologic findings in these experiments are consistent with those previously reported using HFOV in the premature rabbit and human (I) (Froese A, personal communication) but not with that recently described by Solimano et al. (32) in premature lambs. The apparent discrepancy may lie, as suggested by those authors, in species differences in animal models or in the use of lower mean airway pressures during their studies. There would appear, based on our data and that of others (1, 24) , to be a critical relationship among mean airway pressure, alveolar volume, and the efficacy of HFOV in the management of diffuse alveolar disease. The use of intermittent sighs in the initial phase of these experiments allowed us to find the appropriate Paw and lung volume. Once this was reached, large volume inflations resulted in no improvement or a decrement in oxygenation and could no longer be shown to be of clinical benefit.
These studies clearly support clinical trials of the use of HFOV in the management of infants with HMD. Not only does the appropriate use of HFOV result in lower intraluminal distending pressures and a reduced risk of structural disruption, but it appears to favorably alter the "natural" progression of HMD as seen during treatment with conventional ventilation. Additional studies are necessary both to define the mechanisms of the apparent "protective" effect of HFOV and to develop the most efficacious clinical strategy for its use.
